Opinion: The smart way to regulate the peptide boom
“The FDA should pursue a structured, clinician-guided framework” on popular peptides, writes former surgeon general Jerome Adams.
“The FDA should pursue a structured, clinician-guided framework” on popular peptides, writes former surgeon general Jerome Adams.